While the prevention of atrial fibrosis was achievable in younger mice by therapy beginning before the development of fibrosis, we next questioned whether selective blockade of miR-31-5p/CALCR binding could exert a therapeutic effect on established atrial fibrosis (commonly observed in persAF patients) and arrhythmia. Here, CALCR is linked to cardiac arrhythmia.